Methotrexate infusion in low-risk gestational trophoblastic disease

American Journal of Obstetrics and Gynecology

Volumn 183, Issue 6, 2000, Pages 1579-1582

  Wong, Ling Chui ^a   Ngan, Hextan Y S ^a   Cheng, Danny K L ^a   Ng, Tong Yow ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Folinic acid rescue; Low risk gestational trophoblastic disease; Methotrexate infusion

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; DACTINOMYCIN; FOLINIC ACID; METHOTREXATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG EFFICACY; DRUG INDICATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RISK ASSESSMENT; STEVENS JOHNSON SYNDROME; TROPHOBLASTIC DISEASE;

EID: 0034519035     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.108077     Document Type: Article

References (17)

1. Effects of methotrexate therapy upon choriocarcinomas and chorioadenomas
2. Primary, chemotherapy for non-metastatic gestational trophoblastic neoplasm
3. Treatment of non-metastatic gestational trophoblastic disease. Results of methotrexate alone versus methotrexate-folinic acid
4. Methotrexate with citrovorum factor rescue in gestational trophoblastic disease
5. Infusion therapy for pelvic trophoblastic tumors
6. Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic diseases
7. Methotrexate with citrovorum factor rescue: Reduced chemotherapy toxicity in the management of gestational neoplasms
8. Weekly intramuscular methotrexate for non-metastatic gestational trophoblastic disease
9. Etoposide, methotrexate and bleomycin in drug-resistant gestational trophoblastic disease
10. High-dose methotrexate for gestational trophoblastic disease
11. High-dose methotrexate. A critical reappraisal
12. Single-agent chemotherapy for non-metastatic gestational trophoblastic neoplasia: Perspectives for the 21st century after three decades of use
13. Non-metastatic and low-risk metastatic gestational trophoblastic neoplasms
14. 5-Day methotrexate for women with metastatic gestational trophoblastic disease
15. Ten years experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease
16. Methotrexate infusion and folinic acid in the primary therapy of non-metastatic gestational trophoblastic tumors
17. A single institution experience with weekly intramuscular methotrexate for non-metastatic gestational trophoblastic disease